Article Details
Retrieved on: 2019-05-16 05:56:15
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>But the facts of Novartis were unique, and <b>Intellectual Ventures</b> involves another court's finding that the scope of IPR estoppel post-trial is narrow.</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here